BrainsWay Ltd. has grown revenue 11% a year over three years and 12% a year over five. Revenue growth, 3-year annual rate: +11% (Medical Devices median +12%). Revenue growth, 5-year rate: +12%, growth has slowed since the five-year average. Years of annual history on file: 8, FY2017 to FY2024, as filed.

BWAYBrainsWay Ltd.

Healthcare

$11.44+50% 1Y

$11.44

$7.2552 weeks$17.17

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +29% year on year and operating margin widening (+25.3 points), but earnings down −138% year on year.

2 good, 1 to watch

Revenue trend+29% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +12% a year.

Earnings trend−138% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+25.3 points operating

Trailing-twelve-month operating margin, 3.4% now against -21.9% a year earlier.

All from SEC EDGAR, as of Dec 31, 2024.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BWAY growing?

BrainsWay Ltd. has grown revenue 11% a year over three years and 12% a year over five.

+11%

Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from fiscal years as filed

Revenue growth, 5-year rate: +12%
Revenue growth, 5-year rate · +11% over three · growth has slowed since the five-year average
Years of annual history on file: 8
Years of annual history on file · FY2017 to FY2024, as filed

Details›